16/03/2025 18:19 Nightclub fire kills 59 people in North Macedonia
16/03/2025 18:19 Macron says French-British blueprint doesn’t foresee deploying a ‘mass’ of soldiers in Ukraine
16/03/2025 18:19 An assailant sets a woman on fire on a tram in eastern Germany and flees
16/03/2025 16:20 Video: Israeli attacks kill Palestinians in Gaza as ceasefire talks stall
16/03/2025 16:20 Roadside nets aim to thwart Russian drone attacks in Ukraine
16/03/2025 16:20 ‘Unimaginable loss’: North Macedonia reels from deadly nightclub fire
16/03/2025 14:20 A closer look at the unknown Brazilian fox
16/03/2025 14:20 With biological and cultural diversity at literal crossroads in the tropics, a new approach is needed (commentary)
16/03/2025 14:20 Lives worth living: Elephants, Iain Douglas-Hamilton and the fight for coexistence
16/03/2025 12:20 West African climate finance platform seeks local experts

Zepbound sales keep soaring, despite demand for weight-loss drugs growing slower than expected

Home » Business » Zepbound sales keep soaring, despite demand for weight-loss drugs growing slower than expected

Zepbound sales keep soaring, despite demand for weight-loss drugs growing slower than expected

Bruce Gil 06/02/2025 18:19

Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter, despite missing the company’s initial sales expectations.Read more…

Quartz
Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter, despite missing the company’s initial sales expectations.Read more…
Read More